Composition comprising azole fungicide and water soluble metal salt
Granted 24 Jun 2014 · 2 office actions
Assignee: Unilever plc
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Graham Andrew Turner, Richard Livesey Evans, Jason Shaun Burry · Examiner: Sarah Pihonak · AU 1627 · TC 1600
Life of the application
12 dated eventsAbstract
Hair treatment composition comprising an azole fungicide and zinc gluconate and wherein the composition does not comprise Trichogen®.
Description
3 parts›The present invention relates to compositions for treating…
The present invention relates to compositions for treating or preventing hair fall.
Despite the prior art there remains a need for improved compositions for treating or preventing hair fall.
Accordingly, there is provided a hair treatment composition comprising an azole fungicide and zinc gluconate, and wherein the composition does not comprise Trichogen® Veg LS 8960.
Preferably, the azole fungicide is climabazole or ketoconazole.
Preferably, the azole is present at from 0.0001 to 1% wt. of the composition.
Preferably, the zinc gluconate is present at from 0.001 to 2% wt. of the composition. More preferably, the composition comprises from 0.005 to 1% wt. of the composition.
Preferably, the composition does not comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promotor and mixtures thereof.
Preferably the composition does not comprises a synergistic trichogenic mixture of a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts, particularly sulfopeptides of soy and amino acids, especially tyrosine, arginine, ornithine and citrulline. Preferably, the composition does not comprise a glycosamino production agent selected from the group consisting of glucosamine, L-fucose; fucose rich polysaccharide, xylose, vitamin C, Eriobotrya japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof. Particularly preferred is glucosamine.
Preferably, the composition does not comprise a cell nutrition regulator especially vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof. Particularly preferred are vitamins of the B group, especially PP, B5 and biotin.
Preferably, the composition does not comprise a microcirculation promoter, more preferably a microcirculation promoter selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.
Preferably, the composition does not comprise a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.
Preferably, the composition does not comprise a glycosamino production agent selected from glucosamine, L-fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.
Preferably, the composition does not comprise a cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.
Preferably, the composition does not comprise a microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.
Most preferably, the composition does not comprise Trichogen® ex Cognis, in particular Trichogen® Veg LS 8960.
Trichogen® Veg LS 8960. contains:
Panax Ginseng Root Extract, Arginine, Acetyl Tyrosine, Arctium Majus Root Extract, Hydrolysed Soy Protein, Zinc gluconate, Niacinamide, Biotin, Salvia Sclarea Extract, Cinnamomumb Zeylanicum Extract, Ginko Biloba Extract and Kigela Africanal Extract.
The composition according to the invention may be in any product form, e.g. shampoo, mousse, conditioner, gel, mask and may be a rinse-off product or a leave-on product.
Depending on product form the composition according to the invention may also comprise any common ingredients typically found in such product form. For example, a shampoo will likely comprise cleansing surfactants; a conditioner will comprise conditioning agents selected from fatty alcohols, silicone and cationic surfactants, etc.
The invention will now be described with reference to the following embodiments.
›EXAMPLE 1
The following are formulations according to embodiments of the invention.
Leave-on formulations
Shampoo examples
Conditioners
›EXAMPLE 2
The following shows how zinc gluconate and climbazole provide an improved anti-trypsin effect.
1. Zinc Gluconate (0.00156%) plus climbazole
2. Zinc Gluconate (0.003125%) plus climbazole
3. Zinc Gluconate (0.00625%) plus climbazole
›Tables in the description — 3
| A | B | C | D | E | F | |
|---|---|---|---|---|---|---|
| Water and | To | To | To | To | To | To |
| minors | 100% | 100% | 100% | 100% | 100% | 100% |
| Natrosol | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 250HHR | ||||||
| Glycerol | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Zinc | 0.1 | 0.1 | 0.05 | 0.05 | 0.001 | 0.006 |
| gluconate | ||||||
| Climbazole | 0.02 | 0.001 | 0.02 | 0.001 | 0.008 | 0.06 |
| Ethanol | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Water and minors | To 100% | To 100% | To 100% | To 100% |
|---|---|---|---|---|
| Climbazole | 0.5 | 0.5 | 0.5 | 0.5 |
| Zinc gluconate | 1.0 | 0.8 | 0.4 | 0.5 |
| Texapon N70 | 7.70 | 7.70 | 7.70 | 7.70 |
| Mackanate EL | 12.50 | 12.50 | 12.50 | 12.50 |
| Tegobetaine | 9.60 | 9.60 | 9.60 | 9.60 |
| Jaguar C13S | 0.15 | 0.15 | 0.15 | 0.15 |
| Jaguar C17 | 0.05 | 0.05 | 0.05 | 0.05 |
| Sodium Hydroxide | 0.05 | 0.05 | 0.05 | 0.05 |
| (50%) |
| Water | To 100% | To 100% |
|---|---|---|
| Lexamine S13 | 1.25 | 1.25 |
| Ganamin BTLF | 1.25 | 1.25 |
| Laurex CS | 5.00 | 5.00 |
| Potassium Chloride | 0.10 | 0.10 |
| EDTA | 0.10 | 0.10 |
| Lauric Acid | 0.30 | 0.30 |
| Zinc gluconate | 1.0 | 1.0 |
| Climbazole | 0.5 | 0.2 |
| Propylene glycol | 2.0 | 2.0 |
Claims as granted
1 claimLog in to read the claims of this application.
Log in to unlockClassifications
11 codes- A61K31/415
- A01N43/50
- A61K31/315
- A01N55/02
- C07D233/54
- C07F3/00
- C07D233/60
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock